Compare Bills

Primary Sponsor

Last Action

Ref To Com On Rules, Calendar, and Operations of the House2025-04-02

Vote Breakdown

No floor votes recorded.

Plain Language Summary

This bill requires prescription drug manufacturers to notify state agencies, insurance companies, and pharmacy benefits managers at least 60 days before implementing price increases of 10% or more, and to disclose justifications, marketing budgets, and price history within 30 days. It also requires manufacturers to disclose dependency risks when marketing drugs to prescribers and establishes a public online portal where North Carolinians can access pricing information and reports on the state's most prescribed and costliest drugs.

Arguments in Favor

• •Supporters argue this bill increases transparency in prescription drug pricing, helping patients, insurers, and state agencies understand why drugs cost what they do and plan accordingly.
• •They contend that advance notice of price increases gives stakeholders time to respond and that public access to pricing data empowers consumers to make informed decisions and holds manufacturers accountable for pricing decisions.

Arguments Against

• •Opponents may argue the bill places administrative burdens on manufacturers and could discourage innovation or drug development in North Carolina.
• •They may also contend that manufacturers could limit disclosures by relying on the 'publicly available information' exemption, making the transparency requirements less effective, and that the civil penalties of up to $1,000 per day could be excessive.